Presentation Information

9:15 AM - 9:30 AM JST(12:15 AM - 12:30 AM UTC)Presentation by Applicant for JSAP Young Scientists Presentation Award

[7a-N323-2]Investigation of antitumor effects by repeated PAL treatment

〇(M1)Ryo Wakatsukasa¹, Camelia Miron², Kae Nakamura², Kenji Ishikawa², Masaru Hori², Hiromasa Tanaka² (1.Nagoya Univ. Eng., 2.Nagoya Univ.)

Keywords:

plasma medicine

Plasma-activated lactated Ringer’s solution (PAL) has attracted attention as a novel cancer treatment, however, whether cancer cells can acquire resistance to PAL remains unconfirmed. Therefore, we investigated changes in PAL sensitivity based on cell viability in P-MCF-7 cells, which were generated by repeatedly treating human breast cancer cells (MCF-7) with PAL. The results showed that P-MCF-7 cells exhibited reduced sensitivity to PAL. However, the degree of resistance is considered to be relatively small.

Back to Session information